Cmed Group, a combination of a full service CRO and an eClinical solutions provider, has appointed Andrew Kellett as a new chief financial officer (CFO).
Prior to Cmed, Kellett was the finance director of Genetix Group Plc, a global life sciences diagnostics and digital pathology company.
Cmed chief executive David Connelly said that they are delighted to welcome Andrew Kellett to the Cmed team.
“Andrew joins at a pivotal moment in Cmed’s growth and development and brings a wealth of experience in global financial operations and strategy. Andrew’s expertise and knowledge of the financial arena will play an essential part in helping us achieve our goals,” Connelly said.
Kellett said that he is very pleased to be joining Cmed at such an exciting time in its development and is greatly looking forward to working with the Cmed team as the company further builds the business and realise its full potential.